Snowball logo
logo
VVEO

CM Hospitalar SA

VVEO3 SA
R$0.62+R$0.02  (3.33%)
Estimate
P/E
10.3
EPS
0.06
Beta
0.661
Growth
Revenue, YoY
1.69%
Net income, YoY
3.27%
FCF, YoY
41.5%
Forecast
P/E (FWD)
7
EPS (FWD)
0.088
About the company
Ticker
VVEO3
ISIN
Country
Brazil
Sector (GICS)
Healthcare
CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers material products for cardiac, surgical, urinary, diagnosis, sterilization, wound management, hygiene and protection, infusion, clinical nutrition, orthopedic, and respiratory; and medications, such as painkillers, anesthetics, anti-allergy, antibiotics, antiemetics, antifungals, anti-inflammatory, special control, several, and oncology. It also provides materials for respiratory assistance, therapy, anti-inflammatories, anti-tnf, antacid, antiandrogens, antianemics, anti-asthmatics, antibiotics, anticoagulant, anticonvulsant, monoclonal antibody, anti-growth, antidepressants, antidiabetic drug, antidiuretics, antidote, antiemetics and antinauseants, anti-migraine, antiepileptics, antiestrogens, antifibrinolytics, antiflatulents, antifungals, antihemorrhagic drug, antimicrobial, antineoplastics, antiparathyroid, antiparkinsonian, antipsychotics, systemic antipsoriasis, antirheumatic drugs, anti-varicose, antivirals, beta-blockers, carbohydrate, cycloplegic, contraceptives, contrast, special control, corticosteroids, topical debriding agent, diuretics, several, electrolyte, pancreatic enzyme, erythropoietins, uterine stimulant, cardiac stimulators, growth factor, granulocyte colony stimulating factor, gastroprokinetics, systemic hemostatics, heparins, hepatoprotective and lipotropic agents, hormone, adenohypophyseal hormones, growth hormones, immunoglobulins, immunosuppressants, labor induction drugs, proton pump inhibitor, phosphodiesterase and bone resorption inhibitor, platelet aggregation inhibitors, adenosine diphosphate receptor antagonists, proton pump inhibitors, interleukin inhibitors, subtilisin/kexin type 9 proprotein convertase inhibitors, calcium reabsorption inhibitors, materials, medications, nutrition, therapy, orthopedic therapy. CM Hospitalar S/A was incorporated in 2010 and is headquartered in São Paulo, Brazil.

Frequently asked questions

What sector does CM Hospitalar SA (VVEO3) operate in?

CM Hospitalar SA belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is CM Hospitalar SA (VVEO3) current stock price?

As of the latest data, CM Hospitalar SA stock price is R$0.62, with a previous close of R$0.60. CM Hospitalar SA gained R$0.02 in the last trading session, representing a 3.33% increase.

What is CM Hospitalar SA (VVEO3) current market capitalization?

CM Hospitalar SA market cap is approximately 195.88 million.

What is CM Hospitalar SA (VVEO3) Earnings Per Share (EPS)?

The trailing EPS is R$0.06, and the forward EPS is R$0.09.

What is CM Hospitalar SA (VVEO3) Price-to-Earnings (P/E) ratio?

CM Hospitalar SA current P/E ratio is 10.33, with a forward P/E of 7.03.

Does CM Hospitalar SA (VVEO3) pay dividends?

No. CM Hospitalar SA does not pay a dividend.

How did CM Hospitalar SA (VVEO3) perform in its most recent earnings report?

In the last report (March 31, 2026), CM Hospitalar SA posted an EPS surprise of 38.89% and a revenue surprise of -4.45%.

What is CM Hospitalar SA (VVEO3) beta (volatility) score?

CM Hospitalar SA has a beta of 0.661, indicating lower volatility than the overall market.